The 69th Edition of the British National Formulary has been published. As previously noted, the BNF will now only be distributed annually in the NHS.
New or revised content in this version includes updated advice in the following areas:
- Updated general guidance on drugs and driving in response to new regulations in force from March 2015
- Updated guidance on risk assessment and treatment in the management of arrhythmias
- Updated recommendations on minimising risk of osteonecrosis of the jaw and hypocalcaemia associated with denosumab following new MHRA advice
- New guidance on dose adjustment in renal impairment for atorvastatin
- New recommendations on concomitant use of drugs affecting the renin-angiotensin system
- New guidance on dose adjustment in hepatic and renal impairment for zolpiclone
- Updated guidance on assessing cardiovascular risk and modification of blood lipids in the primary and secondary prevention of cardiovascular disease
- Updates to recommended regimens for prophylaxis against malaria for specific countries
Action: All clinicians should start using BNF 69 via electronic methods were possible. The web version can be used to access the latest information if necessary.
|« Rupatadine discontinued||SMC Update - April 2015 »|